Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting pulmonary capillary permeability to reduce lung congestion in heart failure: a randomized, controlled pilot trial
Glenn M. Stewart, Bruce D. Johnson, Dennis L. Sprecher, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 9, pp. 1641-1645
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Heart failure: an update from the last years and a look at the near future
Mauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3667-3693
Open Access | Times Cited: 49
Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders
Martin C. Michel, Linda Cardozo, Christopher Chermansky, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 4, pp. 554-674
Closed Access | Times Cited: 37
Gain-of-function mutations of TRPV4 acting in endothelial cells drive blood-CNS barrier breakdown and motor neuron degeneration in mice
Jeremy M. Sullivan, Anna M. Bagnell, Jonathan Alevy, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 748
Open Access | Times Cited: 10
Targeting gut S. aureofaciens Tü117 serves as a new potential therapeutic intervention for the prevention and treatment of hypertension
Tingting Zhou, Zhiwei Wang, Xiaowang Lv, et al.
Cell Metabolism (2025) Vol. 37, Iss. 2, pp. 496-513.e11
Closed Access | Times Cited: 1
Research progress of TRPV4 in pain over the past 20 years: a bibliometric analysis
Lele Huang, Qiwen Xuan, Ying Li, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Urgent reconsideration of lung edema as a preventable outcome in COVID-19: inhibition of TRPV4 represents a promising and feasible approach
Wolfgang M. Kuebler, Sven‐Eric Jordt, Wolfgang Liedtke
AJP Lung Cellular and Molecular Physiology (2020) Vol. 318, Iss. 6, pp. L1239-L1243
Open Access | Times Cited: 66
Stretching the Function of Innate Immune Cells
E.M. Orsini, Apostolos Perelas, Brian D. Southern, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 55
TRPV4 antagonists: a patent review (2015–2020)
Brian G. Lawhorn, Edward J. Brnardic, David J. Behm
Expert Opinion on Therapeutic Patents (2021) Vol. 31, Iss. 9, pp. 773-784
Closed Access | Times Cited: 36
Diverse Roles of TRPV4 in Macrophages: A Need for Unbiased Profiling
Thanh-Nhan Nguyen, Ghizal Siddiqui, Nicholas A. Veldhuis, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 28
Activation of transient receptor potential vanilloid 4 is involved in pressure overload-induced cardiac hypertrophy
Yan Zou, Miaomiao Zhang, Qiongfeng Wu, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 22
The contribution of ion channels to shaping macrophage behaviour
Anna Selezneva, Alasdair J. Gibb, Dean Willis
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Hypoxaemia in patients with heart failure and preserved ejection fraction
Massar Omar, Kazunori Omote, Hidemi Sorimachi, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 9, pp. 1593-1603
Open Access | Times Cited: 10
Pancreatic stellate cell: Update on molecular investigations and clinical translation in pancreatic cancer
Yawei Liu, Ran Xue
International Journal of Cancer (2025)
Closed Access
TRPV4 in cerebral small vessel disease: A key interacting partner
Sara Lambrichts, Robert J. van Oostenbrugge, Sébastien Foulquier
Vascular Pharmacology (2025), pp. 107492-107492
Open Access
TRPV4 inhibition suppresses myocardial ischemic-reperfusion arrhythmia of mice by alleviating calcium handling abnormalities
Shuaitao Yang, Jiu Pu, Jinfang Yu, et al.
Heart Rhythm (2025)
Closed Access
Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium
Mengnan Wang, Benedikt Preckel, Coert J. Zuurbier, et al.
Basic Research in Cardiology (2025)
Open Access
Reduced Post-ischemic Brain Injury in Transient Receptor Potential Vanilloid 4 Knockout Mice
Kõji Tanaka, Shoji Matsumoto, Takeshi Yamada, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 27
Transient receptor potential channels in pulmonary chemical injuries and as countermeasure targets
Satyanarayana Achanta, Sven‐Eric Jordt
Annals of the New York Academy of Sciences (2020) Vol. 1480, Iss. 1, pp. 73-103
Open Access | Times Cited: 26
Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction
Marco Guazzi, Robert Naeije
Circulation Heart Failure (2021) Vol. 14, Iss. 4
Open Access | Times Cited: 22
Effect of TRPV4 Antagonist GSK2798745 on Chlorine Gas-Induced Acute Lung Injury in a Swine Model
Meghan S. Vermillion, Nathan Saari, M. A. Bray, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3949-3949
Open Access | Times Cited: 3
Combined clinical, structural, and cellular studies discriminate pathogenic and benign TRPV4 variants
Sarah H. Berth, Linh K. Vo, Do Hoon Kwon, et al.
Brain (2024) Vol. 148, Iss. 2, pp. 564-579
Closed Access | Times Cited: 3
Subclinical Pulmonary Congestion and Abnormal Hemodynamics in Heart Failure With Preserved Ejection Fraction
C. Charles Jain, Juerg Tschirren, Yogesh N.V. Reddy, et al.
JACC. Cardiovascular imaging (2021) Vol. 15, Iss. 4, pp. 629-637
Open Access | Times Cited: 19
Novel Analgesics with Peripheral Targets
Cosmin I. Ciotu, Michael J. M. Fischer
Neurotherapeutics (2020) Vol. 17, Iss. 3, pp. 784-825
Open Access | Times Cited: 17
Identification, Synthesis, and Characterization of a Major Circulating Human Metabolite of TRPV4 Antagonist GSK2798745
Joseph E. Pero, John J. McAtee, David J. Behm, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 9, pp. 1498-1502
Open Access | Times Cited: 15
TRP channel function in platelets and megakaryocytes: basic mechanisms and pathophysiological impact
Kalina Kazandzhieva, Elmina Mammadova‐Bach, Alexander Dietrich, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108164-108164
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top